Subgroup analyses showed that patients treated with platinum-based agents and taxanes had the highest prevalence of chronic ...
Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...
Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around four in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...
Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.
"The most severe effects of Vitamin A deficiency are seen in young children and pregnant women in low-income countries," ...
Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence rev ...
Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...
Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...